Literature DB >> 21508012

Modelling the performance of isoniazid preventive therapy for reducing tuberculosis in HIV endemic settings: the effects of network structure.

H L Mills1, T Cohen, C Colijn.   

Abstract

Individuals living with HIV experience a much higher risk of progression from latent M. tuberculosis infection to active tuberculosis (TB) disease relative to individuals with intact immune systems. A several-month daily course of a single drug during latent infection (i.e. isoniazid preventive therapy (IPT)) has proved in clinical trials to substantially reduce an HIV-infected individual's risk of TB disease. As a result of these findings and ongoing studies, the World Health Organization has produced strong guidelines for implementing IPT on a community-wide scale for individuals with HIV at risk of TB disease. To date, there has been limited use of IPT at a community-wide level. In this paper, we present a new co-network model for HIV and TB co-epidemics to address questions about how the population-level impact of community-wide IPT may differ from the individual-level impact of IPT offered to selected individuals. In particular, we examine how the effect of clustering of contacts within high-TB incidence communities may affect the rates of re-infection with TB and how this clustering modifies the expected population-level effects of IPT. We find that populations with clustering of respiratory contacts experience aggregation of TB cases and high numbers of re-infection events. While, encouragingly, the overall population-level effects of community-wide IPT appear to be sustained regardless of network structure, we find that in populations where these contacts are highly clustered, there is dramatic heterogeneity in the impact of IPT: in some sub-regions of these populations, TB is nearly eliminated, while in others, repeated re-infection almost completely undermines the effect of IPT. Our findings imply that as IPT programmes are brought to scale, we should expect local heterogeneity of effectiveness as a result of the complex patterns of disease transmission within communities.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21508012      PMCID: PMC3163428          DOI: 10.1098/rsif.2011.0160

Source DB:  PubMed          Journal:  J R Soc Interface        ISSN: 1742-5662            Impact factor:   4.118


  38 in total

1.  The web of human sexual contacts.

Authors:  F Liljeros; C R Edling; L A Amaral; H E Stanley; Y Aberg
Journal:  Nature       Date:  2001-06-21       Impact factor: 49.962

2.  Beneficial and perverse effects of isoniazid preventive therapy for latent tuberculosis infection in HIV-tuberculosis coinfected populations.

Authors:  Ted Cohen; Marc Lipsitch; Rochelle P Walensky; Megan Murray
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-21       Impact factor: 11.205

3.  The implications of network structure for epidemic dynamics.

Authors:  Matt Keeling
Journal:  Theor Popul Biol       Date:  2005-02       Impact factor: 1.570

4.  Exogenous re-infection and the dynamics of tuberculosis epidemics: local effects in a network model of transmission.

Authors:  Ted Cohen; Caroline Colijn; Bryson Finklea; Megan Murray
Journal:  J R Soc Interface       Date:  2007-06-22       Impact factor: 4.118

5.  Prospects for worldwide tuberculosis control under the WHO DOTS strategy. Directly observed short-course therapy.

Authors:  C Dye; G P Garnett; K Sleeman; B G Williams
Journal:  Lancet       Date:  1998-12-12       Impact factor: 79.321

6.  Whole-genome sequencing and social-network analysis of a tuberculosis outbreak.

Authors:  Jennifer L Gardy; James C Johnston; Shannan J Ho Sui; Victoria J Cook; Lena Shah; Elizabeth Brodkin; Shirley Rempel; Richard Moore; Yongjun Zhao; Robert Holt; Richard Varhol; Inanc Birol; Marcus Lem; Meenu K Sharma; Kevin Elwood; Steven J M Jones; Fiona S L Brinkman; Robert C Brunham; Patrick Tang
Journal:  N Engl J Med       Date:  2011-02-24       Impact factor: 91.245

Review 7.  Isoniazid for preventing tuberculosis in non-HIV infected persons.

Authors:  M J Smieja; C A Marchetti; D J Cook; F M Smaill
Journal:  Cochrane Database Syst Rev       Date:  2000

8.  Changing concepts of "latent tuberculosis infection" in patients living with HIV infection.

Authors:  Stephen D Lawn; Robin Wood; Robert J Wilkinson
Journal:  Clin Dev Immunol       Date:  2010-09-26

9.  Controlling Co-Epidemics: Analysis of HIV and Tuberculosis Infection Dynamics.

Authors:  Elisa F Long; Naveen K Vaidya; Margaret L Brandeau
Journal:  Oper Res       Date:  2008       Impact factor: 3.310

10.  Mining social mixing patterns for infectious disease models based on a two-day population survey in Belgium.

Authors:  Niel Hens; Nele Goeyvaerts; Marc Aerts; Ziv Shkedy; Pierre Van Damme; Philippe Beutels
Journal:  BMC Infect Dis       Date:  2009-01-20       Impact factor: 3.090

View more
  9 in total

1.  How host heterogeneity governs tuberculosis reinfection?

Authors:  M Gabriela M Gomes; Ricardo Aguas; João S Lopes; Marta C Nunes; Carlota Rebelo; Paula Rodrigues; Claudio J Struchiner
Journal:  Proc Biol Sci       Date:  2012-02-22       Impact factor: 5.349

2.  Impact of isoniazid preventive therapy for HIV-infected adults in Rio de Janeiro, Brazil: an epidemiological model.

Authors:  David W Dowdy; Jonathan E Golub; Valeria Saraceni; Lawrence H Moulton; Solange C Cavalcante; Silvia Cohn; Antonio G Pacheco; Richard E Chaisson; Betina Durovni
Journal:  J Acquir Immune Defic Syndr       Date:  2014-08-15       Impact factor: 3.731

Review 3.  Controlling the seedbeds of tuberculosis: diagnosis and treatment of tuberculosis infection.

Authors:  Molebogeng X Rangaka; Solange C Cavalcante; Ben J Marais; Sok Thim; Neil A Martinson; Soumya Swaminathan; Richard E Chaisson
Journal:  Lancet       Date:  2015-10-26       Impact factor: 79.321

4.  Sampling Networks from Their Posterior Predictive Distribution.

Authors:  Ravi Goyal; Victor De Gruttola; Joseph Blitzstein
Journal:  Netw Sci (Camb Univ Press)       Date:  2014-04-01

Review 5.  Data needs for evidence-based decisions: a tuberculosis modeler's 'wish list'.

Authors:  D W Dowdy; C Dye; T Cohen
Journal:  Int J Tuberc Lung Dis       Date:  2013-07       Impact factor: 2.373

Review 6.  Mixed-strain mycobacterium tuberculosis infections and the implications for tuberculosis treatment and control.

Authors:  Ted Cohen; Paul D van Helden; Douglas Wilson; Caroline Colijn; Megan M McLaughlin; Ibrahim Abubakar; Robin M Warren
Journal:  Clin Microbiol Rev       Date:  2012-10       Impact factor: 26.132

7.  Tuberculosis in Cape Town: An age-structured transmission model.

Authors:  Nello Blaser; Cindy Zahnd; Sabine Hermans; Luisa Salazar-Vizcaya; Janne Estill; Carl Morrow; Matthias Egger; Olivia Keiser; Robin Wood
Journal:  Epidemics       Date:  2015-10-20       Impact factor: 4.396

Review 8.  How can mathematical models advance tuberculosis control in high HIV prevalence settings?

Authors:  R M G J Houben; D W Dowdy; A Vassall; T Cohen; M P Nicol; R M Granich; J E Shea; P Eckhoff; C Dye; M E Kimerling; R G White
Journal:  Int J Tuberc Lung Dis       Date:  2014-05       Impact factor: 2.373

Review 9.  Contact tracing of tuberculosis: a systematic review of transmission modelling studies.

Authors:  Matt Begun; Anthony T Newall; Guy B Marks; James G Wood
Journal:  PLoS One       Date:  2013-09-04       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.